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Abstract
Purpose This study tests the value of a measure of eating disorder (ED) psychopathology in predicting outcome following 
guided self-help in a non-underweight sample with regular binge eating. It examines whether early reductions in ED psy-
chopathology are associated with remission status at post-treatment.
Methods Seventy-two adults with bulimia nervosa, binge-eating disorder, or an atypical form of these illnesses received up 
to ten sessions of cognitive behaviour therapy-based guided self-help. Using a session-by-session measure of eating pathol-
ogy and associated reliable change indices, response was analysed using receiver operating characteristic analysis to predict 
outcomes at post-treatment.
Results In this routine care setting, nearly one-quarter of the sample achieved remission following GSH, approximately 
two-thirds of whom showed early change in ED psychopathology. Early change prior to session 6 was accurate in predicting 
later remission. Individuals showing early change did not differ from others on baseline characteristics or rates of attrition.
Conclusion Data suggest that a majority of those who respond to treatment will do so before the second half of treatment, 
information that could be used to ensure that evidence-based treatments are used as effectively as possible.
Level of evidence Level III.
Keywords Guided self-help · Receiver operating characteristic · Treatment outcome · Binge eating
Introduction
Despite difficulties in accurately predicting outcome follow-
ing psychological treatments, early symptom change (also 
known as rapid response) has emerged as a robust predictor 
across several psychiatric disorders, including eating disor-
ders ([1, 2]; see [3] and [4] for reviews). Early changes in 
both behavioural symptoms and eating disorder (ED) psy-
chopathology are associated with better outcomes following 
outpatient treatments based on cognitive behaviour therapy 
(CBT) [3, 4]. Those who make early change are around twice 
as likely to achieve remission compared to those who do not 
[5], a finding demonstrated in intensive outpatient treatment 
[6], as well as brief [7] and standard [2, 5, 8] CBT for EDs.
Guided self-help (GSH) based on CBT principles is a 
recommended first-line treatment for bulimia nervosa (BN), 
binge-eating disorder (BED), and atypical forms of these ill-
nesses not meeting full diagnostic criteria [9, 10]). If GSH is 
unsuccessful, it is recommended that patients are offered an 
alternative, such as individual or group CBT. Distinguish-
ing individuals who will benefit from continuation of GSH 
from those who might be ‘stepped up’ to a more intensive 
treatment is likely to be more cost-effective, offer wider 
patient choice, and improve outcomes for a greater number 
of patients [11, 12].
Studies in this area considering GSH have commonly 
focused on reduction in binge-eating frequency (typically 
using ≥ 65% reduction from baseline to the fourth treatment 
week; [13, 14]) to determine early change, perhaps given 
that many have focused on single disorders, predominantly 
BED [13–15]. Secondary analysis from randomised con-
trolled trials has often been used, with less data available 
from routine care (or ‘real-world’) settings, and therefore 
may not reflect recommendations that GSH can be used for 
a variety of EDs (i.e., transdiagnostically).
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Varying approaches have been used to study early change 
[15], resulting in substantial heterogeneity regarding the def-
inition of early improvement and the timing of this change 
[4]. Assessing change through a measure of ED psycho-
pathology, as opposed to behaviours, has the advantage 
of being applicable across ED diagnoses [16] as it is not 
restricted to certain features, such as objective binge eating, 
which may not be present in all individuals [17]. Further, 
greater ED psychopathology has been linked to treatment 
response [2, 5–8], future relapse [18], and is more strongly 
associated with ED-related impairment than behavioural 
symptoms [19]. In one study of a transdiagnostic sample of 
individuals receiving CBT [8], early improvements in psy-
chopathology were associated with post-treatment outcome 
whereas binge eating and self-induced vomiting were not. 
Such findings have led to the conclusion that “early change 
in cognitive symptoms may be a stronger factor than behav-
ioural change in predicting outcome in shorter [CBT-based] 
treatments” ([7], p. 65). However, no studies have yet looked 
at the predictive value of ED psychopathology within a sam-
ple receiving GSH in routine care.
The aims of the current study are to investigate whether 
(and the point[s] at which) changes in ED psychopathol-
ogy predict remission in EDs characterised by recurrent 
binge eating following GSH treatment. We will compare 
the baseline characteristics of those who demonstrate change 
to those who do not. We will also look at a behavioural index 
of early change, specifically ≥ 65% reduction in binge eating 
at each week of treatment.
Method
Participants
Data were collected from participants (n = 77) who began 
GSH between September 2016 and May 2018 (the final par-
ticipant ended treatment in June 2018). Each was referred 
to one of two regional centres for the treatment of EDs, part 
of the UK National Health Service (NHS), providing treat-
ment to individuals registered with a local physician on a 
no-fee basis. The services are governed by the same NHS 
Trust although funding arrangements mean that they cover 
different geographical areas (based on where the patient’s 
primary care physician is located). Both were commissioned 
to provide treatment to adults with a diagnosis of an ED 
according to ICD-10 [20] or DSM-5 [21] criteria. As such, 
patient demographics are similar and some staff (see below) 
work across services.
Diagnoses were established according to DSM-5 crite-
ria [21] by qualified clinicians following clinical interview 
and agreed upon during multidisciplinary team meetings. 
Although similar areas are covered by assessing clinicians, 
the clinical interview is not standardised. Conduct of the 
study was approved by the Oxford Health NHS Founda-
tion Trust Quality and Audit Department and deemed 
not to require further ethical approval as it comprised an 
evaluation of routine practice involving retrospective, rou-
tinely collected, de-identified data. Five individuals were 
excluded from the study as they attended the first session 
of treatment and then either failed to attend again (n = 3) 
or declined further treatment (n = 2).
Measures
Baseline measures
At initial assessment with the service, participants 
completed:
1. The EDE-Q [22], a self-report measure of eating 
pathology covering the past 28 days. This question-
naire assesses both cognitive and behavioural aspects 
of EDs and can produce a total score (EDE-Q Global), 
which ranges from 0 to 6, with higher scores indicating 
greater ED psychopathology. The EDE-Q also produces 
frequency ratings of disordered eating behaviours (e.g., 
binge eating, self-induced vomiting). The EDE-Q Global 
has been supported as a reliable measure of symptoms 
representing the “‘common core’ of psychopathological 
features underpinning” an ED ([23], p. 201). McDon-
ald’s ω (used to assess internal consistency reliability) 
was 0.87.
2. The Clinical Impairment Assessment questionnaire 
(CIA; [24]), a 16-item measure which assesses psycho-
social impairment over the past 28 days. Participants rate 
the degree to which their ED symptoms have impacted 
aspects of their life (e.g., “made it difficult to concen-
trate”) on a scale of 0 (not at all) to 3 (a lot). Higher 
scores (range = 0–48) indicate greater impairment and 
McDonald’s ω was 0.90. The CIA has been shown to be 
a useful measure of impairment in similar, transdiagnos-
tic, samples [25].
3. The Clinical Outcomes in Routine Evaluation-Outcome 
Measure (CORE-OM; [26]), a self-report measure of 
psychological distress which has been supported for use 
in ED samples [27]. It comprises 34 items asking par-
ticipants to rate how frequently they have experienced 
each item (e.g., “I have felt tense, anxious or nervous”) 
over the last week. A total score is calculated as a mean 
of scores on all items (rated from 0 to 4), with higher 
scores indicating greater distress. McDonald’s ω was 
0.93.
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Weekly measurement
As part of treatment, participants were asked to complete 
the ED-15 [28], a brief self-report measure designed to 
assess session-by-session change in ED symptoms. Ten 
items assessing ED psychopathology (e.g., “Been preoccu-
pied with thoughts of food and eating”) are scored on a 0–6 
scale reflecting frequency over the past week in addition 
to five items regarding the frequency of disordered eating 
behaviours. The instrument’s developers suggest that two 
subscales (Weight and Shape Concerns; Eating Concerns) 
can be derived from the ten psychopathology items, in 
addition to a total score (the mean of these ten items), a 
model supported in a study of the instrument’s psychomet-
ric properties [29]. As correlations between the subscales 
were high (rs = 0.599), the Total score (McDonald’s ω at first 
session = 0.90) was used to assess psychopathology, similar 
to the study of Raykos et al. [5] using the EDE-Q Global. 
The ED-15 Total has been found to correlate strongly with 
the EDE-Q Global [28, 29], suggesting that they measure 
similar constructs.
Treatment
Participants were provided with a popular self-help book 
which provides psychoeducation and a CBT approach for the 
treatment of broadly defined (i.e., addressing both subjective 
and objective) binge eating [30]. Participants were asked to 
attend a local clinic, weekly at first, for guidance from one 
of four trained facilitators. Participants were asked to attend 
ten face-to-face sessions, provided over 12 weeks. Lasting 
20–25 min, sessions occurred weekly at first, with the final 
two occurring fortnightly. Facilitators comprised junior 
psychologists working for the NHS who attended weekly 
supervision from clinical psychologists with experience pro-
viding CBT and GSH for EDs. Three facilitators provided 
treatment in both locations. The ethos behind the guidance 
is ‘programme-led’, with facilitators supporting patients to 
make change by offering support and encouragement and 
keeping a focus on changing eating behaviour [31].
Reliable and clinically significant change
Jacobson and Truax [32] proposed two metrics to evalu-
ate the impact of psychological therapy. To be considered 
“recovered”, an individual must show reliable change—
where observed change is unlikely to be due to measure-
ment error—and clinically significant change—where scores 
on a measure move from ‘dysfunctional’ population norms 
to those of a ‘functional’ population. Reliable change was 
calculated following the suggested amendment of Chris-
tensen and Mendoza [33], whereby change greater than 1.96 
times the standard error of the difference is unlikely to have 
occurred by chance. In the current study, minimum reliable 
change on the ED-15 Total was 1.34. Regarding calculation 
of clinically significant change, Tatham et al. [28] provide 
scores for both a non-clinical and clinical sample: mean 
(SD) ED-15 Total scores were 2.05 (1.33) and 4.24 (1.09), 
respectively. Given overlapping distributions of these sam-
ples, the midpoint between the two was chosen to represent 
clinical significance (Jacobson and Truax’s Method c; p. 13). 
The resulting value is 3.254, similar to 1SD above the mean 
of the non-clinical sample [34].
Remission classification
Remission was defined by the combination of demonstrating 
a healthy body mass index (BMI) (≥ 19.0 kg/m2), abstinence 
(no episodes of binge eating, vomiting, or laxative use at the 
final session according to the ED-15) and both reliable and 
clinically significant change on the ED-15. This method fol-
lows guidance for defining outcome in EDs [35] and adopts a 
BMI cutoff above which participants are unlikely to experi-
ence adverse effects of being ‘underweight’ [36].
Statistical analyses
Receiver operating characteristic (ROC) analysis was used 
to determine the point(s) at which change predicted remis-
sion at post-treatment. Specifically, the area under the curve 
(AUC) was used to obtain a probability that an individual 
who is deemed to have remitted at post-treatment will show 
change at a given point.
Chi-square or Fisher’s exact test (when sample sizes were 
small) were used for categorical data and non-parametric 
(Mann–Whitney U) tests for continuous data, given the 
presence of non-normality. ROC analysis is typically non-
parametric and does not assume a normal distribution for the 
index test; it is therefore particularly well suited to hypoth-
esis testing in routine care settings and less affected by issues 
such as non-normal distributions [37]. As a secondary aim, 
we report the timing of attrition—the point at which patients 
in GSH no longer attended for further sessions. The (non-
parametric) Kaplan–Meier method was used to estimate tim-
ing of drop-out.
Sample size estimation
To investigate predictors of change using ROC analysis, at 
least 66 participants were desired [38], based on a power 
of 0.8, alpha level of 0.05, and AUC estimates from Nazar 
et al. [4].
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Missing data
ED-15 Total data were missing completely at random (Lit-
tle’s MCAR, Χ2 (111) = 109.825, p = 0.514). To assess the 
possible impact of model misspecification [39], multiple 
imputation (with chained equations) of missing ED-15 Total 
data was conducted, regardless of why data were missing. 
Twenty imputed datasets were created, imputed at scale level 
given high internal consistency [40], with age, diagnosis, 
completer status, BMI, and baseline ED-15 Total as predic-
tors of missing data, in addition to each subsequent ED-15 
Total score. Results did not change the interpretation of data, 
with changes only in AUC estimates, not significance values. 
Data are therefore reported without imputation. It was not 
possible to calculate change indices for one individual who 
did not provide data for Session Two.
Timing of symptom change
To investigate predictors of remission at post-treatment, two 
methods of identifying change in ED psychopathology were 
tested: patients achieving clinically significant change on 
the ED-15 Total (i.e., scoring below 3.254) at each session; 
and patients achieving reliable change (i.e., a reduction in 
ED-15 Total scores of ≥ 1.34 from the first treatment ses-
sion). As some patients did not provide data at Session One, 
we used data from Session Two where this was missing to 
represent the First Session of treatment, from which change 
scores were calculated. To investigate behavioural change, 
individuals were identified who showed ≥ 65% reduction in 




Participants ranged in age from 18 to 79 years (mean = 34.7, 
SD = 12.8). All had BMIs in the non-underweight range 
(> 18.5 kg/m2) and 93.1% were female. Mean (SD) dura-
tion of illness was 17.0 (13.4) years. Based on EDE-Q data 
at baseline (i.e., previous 28 days), mean (SD) binge eating 
frequency was 15.81 (10.05) episodes and mean (SD) Global 
score was 4.32 (0.90). Mean (SD) CIA total was 32.47 (8.43) 
and 1.95 (0.61) for the CORE-OM.
Of 72 individuals who commenced GSH, 50 completed 
all ten sessions and a further 4 completed treatment early; 
thus, attrition was 25.0%. ‘Early completers’ were patients 
who, following satisfactory response to treatment and pro-
gress through the programme, decided with the facilitator 
that further sessions were not required.1 On average, partici-
pants received 8.90 (2.15) sessions of support. Twenty-nine 
individuals (40.3%) reported abstinence at their final session 
and 22 (30.6%) were classified as “recovered” based on reli-
able change indices. Sixteen individuals (22.2%) reported 
both abstinence and recovery and were considered remitted 
for the purposes of this study. Remission was achieved by 
10/38 (26.3%) individuals with BN, 3/12 (25.0%) of those 
with BED, and 3/22 (13.6%) of those with Other Specified 
Feeding and Eating Disorder (OSFED).
Predicting remission
Method 1: clinically significant change
As shown in Table 1, an ED-15 score below 3.254 prior to 
session 8 was significantly associated with remission at post-
treatment, as was change prior to Session 10.
Method 2: reliable change
A decrease in ED-15 Total of at least 1.34 points before ses-
sion 6 was associated with post‐treatment remission status 
(p = 0.007; AUC 95% CiIs 0.610–0.979; Table 2). Achiev-
ing reliable change at future sessions was associated with 
Table 1  ROC analysis of clinically significant change predicting 
remission, including numbers achieving change at each session
Session ED-15 
total < 3.254 
(n)
AUC (95% CI) Standard error p value
First avail-





3 19 0.557 (0.344–
0.770)
0.109 0.596
4 22 0.575 (0.361–
0.789)
0.109 0.486
5 21 0.607 (0.396–
0.818)
0.108 0.320
6 28 0.604 (0.397–
0.810)
0.105 0.336
7 28 0.586 (0.378–
0.793)
0.106 0.426
8 23 0.793 (0.623–
0.963)
0.087 0.007
9 31 0.668 (0.478–
0.857)
0.097 0.119
10 31 0.750 (0.598–
0.902)
0.078 0.020
1 These individuals ended treatment after 6, 7, 8, and 9 sessions 
respectively.
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continued accuracy, except for change prior to session 7 
which only approached significance (p = 0.055; 95% CiIs 
0.505–0.910). ROC curves are presented in Fig. 1 and sug-
gest that reliable change occurring prior to Session 6 can 
identify around two-thirds (11/16) of those who achieve 
remission. 
Fig. 1  ROC curves for reliable 
change and remission
Table 2  ROC analysis of reliable change predicting remission 
(change from first session), including numbers achieving change 




AUC (95% CI) Standard error p value
2 4 0.531 (0.315–0.748) 0.111 0.771
3 7 0.563 (0.344–0.782) 0.112 0.561
4 5 0.581 (0.360–0.803) 0.113 0.452
5 10 0.644 (0.428–0.861) 0.111 0.182
6 17 0.794 (0.610–0.979) 0.094 0.007
7 20 0.707 (0.505–0.910) 0.103 0.055
8 18 0.844 (0.683–1.000) 0.082 0.001
9 22 0.807 (0.639–0.976) 0.086 0.005
10 24 0.852 (0.732–0.972) 0.061 0.001
Table 3  ROC analysis of reduction in binge eating (≥ 65% from base-
line) predicting remission, including numbers achieving change at 
each session
Session ≥ 65% reduction 
in binge eating 
(n)
AUC (95% CI) Standard error p value
2 7 0.558 (0.390–
0.726)
0.086 0.481
3 15 0.567 (0.401–
0.733)
0.085 0.416
4 21 0.513 (0.351–
0.676)
0.083 0.871
5 18 0.500 (0.339–
0.661)
0.082 0.999
6 24 0.688 (0.533–
0.842)
0.079 0.023
7 26 0.589 (0.428–
0.751)
0.083 0.279
8 30 0.594 (0.434–
0.753)
0.081 0.255
9 31 0.625 (0.469–
0.781)
0.080 0.129
10 30 0.634 (0.478–
0.790)
0.080 0.104
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Method 3: behavioural change
A reduction in frequency of binge eating ≥ 65% from 
baseline was predictive of remission only prior to Ses-
sion 6, and this metric otherwise appeared to be a poor 
predictor of remission (Table 3).
Comparison of groups at baseline
Seventeen individuals achieved reliable change prior to Ses-
sion 6 (Method 2). There were no significant differences 
between this group and remaining participants on baseline 
measures (Table 4).
Comparison of treatment outcomes
Those showing reliable change did not differ from others 
on rates of treatment completion (82.4% (14/17) v. 74.1% 
(40/54); p = 0.745, Fisher’s exact test) or number of treat-
ment sessions received (Table 4). Those showing reliable 
change prior to Session 6 were significantly more likely than 
others to achieve remission at post-treatment (64.7% (11/17) 
v. 9.3% (5/54); χ2 (1) = 22.77, p < 0.001, Φ = 0.57).
Table 4  Characteristics of 
groups at baseline (method 2)
Numbers differ as data were not complete for all participants
DOI duration of illness, ARC absence of reliable change group, RC reliable change group
Baseline variable n Mean (SD) Differences between RC and 
ARC 
RC ARC Mann–Whitney U p value
Age, years 71 35.45 (15.31) 34.55 (11.73) 531.00 0.921
BMI, kg/m2 68 29.47 (6.98) 31.08 (9.64) 453.50 0.721
DOI, years 58 16.28 (16.33) 17.38 (12.10) 316.00 0.459
No. of sessions 71 9.64 (0.79) 8.71 (2.30) 463.00 0.241
EDE-Q
 Global 70 4.37 (0.67) 4.26 (0.98) 502.00 0.847
 OBEs 68 18.18 (10.29) 14.87 (9.87) 403.00 0.217
 Self-induced vomiting 69 14.23 (20.53) 10.11 (18.30) 451.00 0.382
 Laxative use 69 1.86 (4.22) 2.70 (5.95) 481.00 0.556
CORE-OM Total 70 1.89 (0.46) 1.96 (0.66) 492.00 0.747
CIA Total 68 33.81 (6.62) 31.67 (9.12) 425.00 0.433
Fig. 2  Survival plot (Kaplan–
Meier Curve) of timing of 
dropout during GSH
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Attrition
Figure 2 presents the survival curve, representing the ses-
sions after which patients no longer attended GSH. As noted 
above, attrition rates were not related to early change status 
and Mann–Whitney U tests suggested no baseline differ-
ences between those who dropped out and those who com-
pleted treatment (Table 5).
Discussion
The current study extended previous research looking at 
early symptom change in GSH for EDs characterised by 
recurrent binge eating. Participants who showed improve-
ments in ED psychopathology before the sixth session of 
treatment were more likely to achieve remission at post-
treatment compared to those who did not. Taken alongside 
studies of longer forms of CBT for EDs [2, 5], the findings 
reinforce the view that early response remains “the only 
consistent indicator of optimal prognosis across treatments” 
([5], p. 767).
The current study, which extends analysis of early change 
to a transdiagnostic sample of individuals receiving GSH, 
found no baseline differences between rapid responders and 
others. Rates of attrition (at around 25%) were similar across 
groups. As previous authors have noted, those who demon-
strate early change are not merely “easy” cases who can be 
identified according to clinical severity ([13], p. 388), a con-
clusion partially supported by the high levels of symptom 
and impairment noted in this sample.
The findings could have potential to expediently identify 
individuals who respond well to low-intensity treatments 
for binge eating and thus inform stepped care models for 
ED treatment [9, 10]. Use of a measure of ED psychopa-
thology suggested that around one-quarter of patients who 
start treatment can be accurately classed as rapid responders 
[5], although this proportion is lower than in other studies 
using behavioural criteria [14, 15]. Assessing early change 
in such a way (as opposed to a behavioural index) can be 
implemented across samples of mixed ED groups [5, 12] to 
predict treatment response and may be particularly useful 
in routine care situations where mixed diagnostic groups 
present for treatment. Further, in the current study, behav-
ioural change was a poor predictor of outcome, although it is 
notable that the only significant association which emerged 
was also prior to Session 6, suggesting that there is an asso-
ciation between early cognitive and behavioural change [8].
Rates of attrition seen in the current study are similar to 
those from systematic reviews [41]. Whilst numbers were 
small, the present findings suggest that attrition occurs over 
the course of treatment, although a large number failed to 
attend the final session (i.e., after Session 9, which was the 
modal number). Given the limited data available, it is dif-
ficult to form conclusions but this could reflect avoidance 
towards the end of treatment or that participants had made 
sufficient gains that they did not feel a final session was nec-
essary [42]. Similar patterns have been observed in group-
based CBT for atypical EDs [43] although other literature 
suggests that attrition tends to occur earlier in treatment [44] 
and reviews in this area have noted the limited data on the 
timing of dropout [41].
Identifying how best to help individuals who do not show 
early change should remain a research priority. More inten-
sive treatment is an option, and several CBT-based interven-
tions for EDs consider ‘therapeutic termination’ of treatment 
if patients appear unable to commit to goals around change 
[45, 46]. The current study suggests that limited change prior 
to Session 6 of GSH could be used to prompt such a discus-
sion, and the findings might inform further research looking 
at patients who benefit from a ‘therapeutic termination’ and 
those who may require more intensive treatment.
Table 5  Characteristics of 
individuals who dropped out 
and those who completed 
treatment
Numbers differ as data were not complete for all participants
DOI duration of illness
Baseline variable n Mean (SD) Group differences
Dropped out Completed Mann–Whitney U p value
Age, years 72 33.56 (9.53) 35.09 (13.76) 486.00 0.999
BMI, kg/m2 68 30.08 (10.87) 30.78 (8.29) 380.50 0.453
DOI, years 58 15.69 (8.59) 17.42 (14.57) 286.50 0.911
EDE-Q
 Global 70 4.22 (0.80) 4.35 (0.94) 393.50 0.317
 OBEs 68 15.13 (11.32) 16.02 (9.74) 385.00 0.653
 Self-induced vomiting 70 7.33 (9.42) 13.10 (21.11) 424.50 0.548
 Laxative use 70 5.50 (9.81) 1.85 (3.95) 363.00 0.077
CORE-OM total 70 1.92 (0.69) 1.97 (0.59) 431.50 0.624
CIA total 68 34.29 (8.79) 31.86 (8.30) 345.00 0.210
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Some limitations of the study are notable. Although a 
comprehensive definition of remission was used, including 
both behavioural and cognitive symptoms, the timeframe 
was short and limited by self-report, thus not representing 
the “gold standard” of assessing outcome in such designs 
[47]. Overlaps in the measures used may have provided arte-
factual correlation towards the end of treatment, although 
findings regarding early change are in line with previous 
work [3]. The study was also limited by recruitment from 
one NHS Trust and provided GSH with ten sessions of sup-
port, more than some GSH studies [15], which may have 
influenced the findings. The sample was intended to repre-
sent a transdiagnostic sample characterised by regular binge 
eating (broadly defined), but small numbers limit generalisa-
tion across the range of EDs, particularly OSFED. Given the 
paucity of validated session-by-session measures in EDs, 
further studies are required to confirm the psychometric 
properties of the ED-15 and similar measures [28] and to 
replicate the findings presented here.
In summary, the current study offers support for use of 
an easily computed measure of symptom change in GSH 
that may be useful in informing stepped-care models [9, 
10]. Monitoring ED psychopathology throughout treatment 
can help clinicians focus on helping patients achieve early 
change [2] and consider tailored approaches for those who 
are likely to respond more slowly [3, 5]. Conducting a formal 
review after around 4 weeks of treatment has been recom-
mended for this purpose [7].
What is already known on this subject?
Early behavioural change has been consistently associated 
with positive outcomes following treatment for EDs. How-
ever, early change in ED psychopathology has been given 
less attention with limited exploration of this variable in 
guided self-help treatment.
What this study adds
This study extends findings regarding the predictive ability 
of early change in ED treatment to include a guided self-help 
approach. Change in ED psychopathology prior to Session 6 
of treatment accurately predicted remission in a transdiag-
nostic sample. The study has implications for stepped care 
models of treatment, including early (non-)response.
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